Investigates boundary refinement and transition characterization in a complex multi-seed setup, suggesting intricate relationships.
This document pre-registers PHILIA-EcoSensory Swarm Phase 3, a planned experiment of 1,540 runs (5 primary cells × N=40 × 7 w-points + 1 replication cell × N=20 × 7 w-points, seeds 1042–1101, T=80,000 steps/run, GX=linear only). Phase 2 (DOI: 10.5281/zenodo.20287362) established CASE_BIPHASIC (primary) and CASE_BOUNDARY (secondary): GX=linear CXZ∈{30,50,70}×10⁻⁶ all supra-NF synergy (best: AUC=−0.004670, 155.7% NF), and H_ARCH zero violation across 4,515 cumulative runs. Phase 3 targets two primary objectives: (1) GX=linear CXZ boundary refinement: LC 100% re-entry CXZ* identification within [70, 90]×10⁻⁶ (grid: 70/75/80/85/90×10⁻⁶). Quadratic extrapolation from retroactive_v10 §P3-1 estimates CXZ*≈89.1×10⁻⁶ (n=4, df=1, raw verification pending). (2) w-axis transition characterization: Q-P3-W bipolar transition direction (synergy→antagonism) replication test + seed-pool dependence assessment via dual baseline comparison (Comparison A: Phase 2 frozen baseline; Comparison B: within-Phase-3 pool reference). Replication cell P3_REP_50 (GX=linear, CXZ=50, seeds 1082–1101, N=20) tests whether Phase 2 transition zone [0.875→0.9] is seed-pool specific. Pre-registration resolves Phase 2 supra-registered ambiguity (§6 Lim 7): CASE priority ordering explicitly specified (CASE_BIPHASIC primary, CASE_BOUNDARY secondary). Phase 2 §5.3 morphology interpretation limitation explicitly acknowledged (DOI-frozen; seed-pool contribution cannot be excluded per retroactive_v10 §P3-2). Design basis: retroactive_v10 §P3 (2026.05.20, new measurement = 0, existing Phase 2 raw only). Controller-Sign Sanity items 10–13b numerically verified (correct_drift_x(0.9)=−0.020247, all 7w PASS). 5-AI adversarial review: 판도라 × 루카스 × 크리스 (44차) × 선비 × 길잡이. Supplement to: DOI 10.5281/zenodo.20287362 (Phase 2 Report)Phase 2 Pre-Registration: DOI 10.5281/zenodo.20256733Phase 1 Closure: DOI 10.5281/zenodo.20256557 실측이 생명. 증명이 아닌 기술. — Trinity AI Research Team | 0∞1∞0.5∞
No takes yet. Share an insight, caveat, or question.
신두섭 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: